デフォルト表紙
市場調査レポート
商品コード
1363035

顎形成術の市場規模、シェア、動向分析レポート:処置別、性別、最終用途別、地域別、セグメント予測、2023年~2030年

Chin Augmentation Market Size, Share & Trends Analysis Report By Procedure (Surgical, Non-Surgical), By Gender (Female, Male), By End-use (Cosmetic Surgery Centers, Hospitals, MedSpas), By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
顎形成術の市場規模、シェア、動向分析レポート:処置別、性別、最終用途別、地域別、セグメント予測、2023年~2030年
出版日: 2023年09月15日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

顎形成術市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の顎形成術の市場規模は2023年から2030年にかけてCAGR 6.8%で推移し、2030年には20億1,000万米ドルに達すると予測されています。

同市場の成長は、審美的ニーズの変化、規制機関による顎の増強のための皮膚フィラーの認知、製造業者と他のサービス仲介業者との協力関係の拡大に起因しています。さらに、世界の高齢化人口の増加は、顔と頭に焦点を当てた様々な美容手術が老化の兆候を描く成人人口に好まれているため、顎形成術の需要を推進しています。2020年の米国形成外科学会(American Society of Plastic Surgeons)の報告によると、ヒアルロン酸ベースのフィラーは40~54歳の人々に主に使用されています。

米国やドイツなどの先進諸国では、月々の費用を分散して美容整形手術の資金を調達することが可能であるため、患者は顎の増強などの美容整形手術を受ける傾向にあります。さらに、皮膚充填剤の主要メーカーは、製品ターゲットへの浸透を高めるために、サービスプロバイダーと積極的に協力しています。例えば、2022年4月、PatientFiとAllergan Aestheticsはマーケティング契約を拡大し、前者は後者の製品ポートフォリオに融資オプションを提供できるようになっています。この契約により、VollumaやVoluxといったジュビダーム充填剤の顎形成術への使用が促進されると予想されます。

さらに、顎形成用の皮膚フィラーの製品承認が増加していることも、市場の成長を後押ししています。例えば、2020年6月、アッヴィはジュビダーム・ヴォルマの顎形成用として米国FDAの承認を取得しました。同様に、2021年2月、Galderma社は、21歳以上の成人における中等度から軽度の顎の後退を修正するRestylane Defyneの規制当局による承認を取得しました。

顎形成術市場レポート・ハイライト

  • 世界市場は2022年に12億米ドルと推定され、2030年には20億1,000万米ドルに達すると予測されます。
  • 2023年から2030年にかけて、世界市場はCAGR6.8%で成長すると予測されます。
  • 2022年には、北米が34.95%の収益シェアで市場を独占しました。この成長は、美容施術の受容性が高まっていること、連邦規制機関からの製品承認が増加していること、サービスプロバイダーの数が増加していることに起因しています。
  • 2022年の売上高シェアは手術セグメントが独占し、市場の69.62%を占めました。
  • 美容外科センターは、高度なインフラが利用可能で、待ち時間が短く、外来患者優先で患者にサービスを提供できることから、2022年の収益シェアは54.92%で市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 顎形成術市場の変数、動向、および範囲

  • 市場系統の見通し
  • 市場動向と展望
  • 市場力学
  • 事業環境分析

第4章 顎形成術市場:処置のビジネス分析

  • 顎形成術市場:処置の動向と市場シェア分析、2022年と2030年
  • 手術
  • 非手術

第5章 顎形成術市場:性別のビジネス分析

  • 顎形成術市場:性別の動向と市場シェア分析、2022年と2030年
  • 女性
  • 男性

第6章 顎形成術市場:最終用途のビジネス分析

  • 顎形成術市場:最終用途の動向と市場シェア分析、2022年と2030年
  • 美容整形センター
  • 病院
  • メッドスパ

第7章 顎形成術市場:地域のビジネス分析

  • 地域の市場スナップショット
  • 国別の市場シェア分析、2022年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業プロファイル・一覧表
    • New York Plastic Surgical Group
    • Westlake Dermatology &Cosmetic Surgery
    • Nazarian Plastic Surgery
    • Ruby Surgery &Aesthetics
    • Cadogan Clinics
    • UK Aesthetic
    • UK Healthcare Aesthetics Center
    • Marroquin &Sandoval Plastic Surgery
    • Advanced Cosmetic Surgery.
    • Orange County Facial Plastic Surgery.
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 List of Secondary Sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Chin Augmentation market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Chin Augmentation Market: Procedure Outlook Key Takeaways
  • Fig. 15 Chin Augmentation Market: Procedure Movement Analysis
  • Fig. 16 Surgical Chin Augmentation Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 17 Chin Implants Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 18 Bone Advancements Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 19 Non-Surgical Chin Augmentation Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Chin Augmentation Market: Gender Outlook Key Takeaways
  • Fig. 21 Chin Augmentation Market: Gender Movement Analysis
  • Fig. 22 Female Chin Augmentation Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Male Chin Augmentation Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Chin Augmentation Market: End-use Outlook Key Takeaways
  • Fig. 25 Chin Augmentation Market: End-use Movement Analysis
  • Fig. 26 Cosmetic Surgery Centers Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Hospitals Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 MedSpas Market Estimates and Forecast Market, 2018 - 2030 (USD Billion)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional outlook, 2022 & 2030
  • Fig. 31 Global Chin Augmentation Market: Region Movement Analysis
  • Fig. 32 North America Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 33 U.S. Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 34 Canada Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 35 Europe Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 36 Germany Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 37 UK Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 38 France Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 39 Italy Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 40 Spain Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 41 Denmark Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 42 Sweden Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 43 Norway Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 44 Asia pacific Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 45 Japan Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 46 China Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 47 India Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 48 Australia Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 49 South Korea Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 50 Thailand Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 51 Latin America Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 52 Brazil Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 53 Mexico Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 54 Argentina Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 55 Middle East and Africa Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 56 South Africa Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 57 Saudi Arabia Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 58 Kuwait Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • Fig. 59 UAE Chin Augmentation Market, 2018 - 2030 (USD Billion)
目次
Product Code: GVR-4-68040-120-6

Chin Augmentation Market Growth & Trends:

The global chin augmentation market size is expected to reach USD 2.01 Billion by 2030, registering at a CAGR of 6.8% from 2023 to 2030, based on a new report by Grand View Research, Inc.. The growth of the market is attributed to the changing aesthetic needs, recognition of dermal fillers for chin augmentation by regulatory bodies, and growing collaboration between manufacturers and other service intermediaries. Moreover, the growing aging population globally propels the demand for chin augmentation as various aesthetic surgeries focused on the face and head are preferred by the adult population who portray signs of aging. According to the American Society of Plastic Surgeons report in 2020, hyaluronic acid-based fillers were used predominantly in those aged between 40 to 54 years.

The availability to finance cosmetic surgeries at distributed monthly cost propels patients to undergo cosmetic procedures such as chin augmentation in developed countries such as the U.S. and Germany. Furthermore, leading manufacturers of dermal fillers are actively collaborating with service providers to increase their product-target penetration. For instance, in April 2022, PatientFi and Allergan Aesthetics expanded their marketing agreement, allowing the former company to provide financing options to the latter's product portfolio. The agreement will propel the usage of Juvederm fillers such as Volluma and Volux for chin augmentation procedures.

In addition, growing product approvals for dermal fillers for chin augmentation applications propels the market growth. For instance, in June 2020, AbbVie received U.S. FDA approval for Juvederm Volluma to augment the chin. Similarly, in February 2021, Galderma received regulatory approval for Restylane Defyne to correct moderate to mild chin retrusion in adults aged 21 and over.

Chin Augmentation Market Report Highlights:

  • The global market was estimated at USD 1.20 billion in 2022 and is expected to reach USD 2.01 billion in 2030
  • The global market is expected to grow at a compound annual growth rate of 6.8% from 2023 to 2030
  • In 2022, North America dominated the market in terms of a revenue share of 34.95%. This growth can be attributed to the increasing acceptability of cosmetic procedures, growing product approvals from federal regulatory bodies, and a rising number of service providers
  • The surgical segment dominated the revenue share in 2022 and accounted for 69.62% in 2022 of the market
  • Cosmetic surgery centers dominated the market with a revenue share of 54.92% in 2022, due to the availability of advanced infrastructure, shorter waiting time, and the ability to serve patients on an outpatient preference

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Volume Price Analysis
      • 1.5.1.1. Approach 1: Volume Price Analysis
  • 1.6. Data Validation & Publishing
  • 1.7. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Chin Augmentation Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Advancement in surgical and non-surgical techniques
      • 3.3.1.2. Increasing product approvals from regulatory bodies
      • 3.3.1.3. Growing number of cosmetic procedures in aging & male population
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Stringent regulatory rule for providers
      • 3.3.2.2. High-cost variability across regions
  • 3.4. Business Environment Analysis
    • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.4.2. Porter's Five Forces Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Chin Augmentation Market: Procedure Business Analysis

  • 4.1. Chin Augmentation Market: Procedure Movement & Market Share Analysis, 2022 & 2030
  • 4.2. Surgical
    • 4.2.1. Surgical Chin Augmentation Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.2.2. Chin Implants
      • 4.2.2.1. Chin Implants Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.2.3. Bone Advancement
      • 4.2.3.1. Bone Advancement Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.3. Non-Surgical
    • 4.3.1. Non-Surgical Chin Augmentation Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Chin Augmentation Market: Gender Business Analysis

  • 5.1. Chin Augmentation Market: Gender Movement & Market Share Analysis, 2022 & 2030
  • 5.2. Female
    • 5.2.1. Female Chin Augmentation Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.3. Male
    • 5.3.1. Male Chin Augmentation Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Chin Augmentation Market: End-Use Business Analysis

  • 6.1. Chin Augmentation Market: End Use Movement & Market Share Analysis, 2022 & 2030
  • 6.2. Cosmetic Surgery Centers
    • 6.2.1. Cosmetic Surgery Centers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. MedSpas
    • 6.4.1. MedSpas Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Chin Augmentation Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. Market Share Analysis by Country, 2022
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. MEA
  • 7.3. North America
    • 7.3.1. North America Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.3.2. U.S.
      • 7.3.2.1. U.S. Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
    • 7.3.3. Canada
      • 7.3.3.1. Canada Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
  • 7.4. Europe
    • 7.4.1. Europe Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.4.2. Germany
      • 7.4.2.1. Germany Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
    • 7.4.3. UK
      • 7.4.3.1. UK Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
    • 7.4.4. France
      • 7.4.4.1. France Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
    • 7.4.5. Italy
      • 7.4.5.1. Italy Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
    • 7.4.6. Spain
      • 7.4.6.1. Spain Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
    • 7.4.7. Denmark
      • 7.4.7.1. Denmark Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
    • 7.4.8. Sweden
      • 7.4.8.1. Sweden Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.4.8.2. Key Country Dynamics
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5.
    • 7.4.9. Norway
      • 7.4.9.1. Norway Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.4.9.2. Key Country Dynamics
      • 7.4.9.3. Competitive Scenario
      • 7.4.9.4. Regulatory Framework
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.5.2. Japan
      • 7.5.2.1. Japan Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
    • 7.5.3. China
      • 7.5.3.1. China Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
    • 7.5.4. India
      • 7.5.4.1. India Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.5.4.2. Key Country Dynamics
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
    • 7.5.5. South Korea
      • 7.5.5.1. South Korea Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.5.5.2. Key Country Dynamics
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
    • 7.5.6. Australia
      • 7.5.6.1. Australia Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.5.6.2. Key Country Dynamics
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Regulatory Framework
    • 7.5.7. Thailand
      • 7.5.7.1. Thailand Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.5.7.2. Key Country Dynamics
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Regulatory Framework
  • 7.6. Latin America
    • 7.6.1. Latin America Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.6.2. Brazil
      • 7.6.2.1. Brazil Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
    • 7.6.3. Mexico
      • 7.6.3.1. Mexico Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
    • 7.6.4. Argentina
      • 7.6.4.1. Argentina Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
  • 7.7. MEA
    • 7.7.1. MEA Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.7.2. South Africa
      • 7.7.2.1. South Africa Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.7.2.2. Key Country Dynamics
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Regulatory Framework
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Saudi Arabia Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.7.3.2. Key Country Dynamics
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Regulatory Framework
      • 7.7.3.5.
    • 7.7.4. UAE
      • 7.7.4.1. UAE Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.7.4.2. Key Country Dynamics
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Regulatory Framework
    • 7.7.5. Kuwait
      • 7.7.5.1. Kuwait Chin Augmentation Market, 2018 - 2030 (USD Billion)
      • 7.7.5.2. Key Country Dynamics
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. Regulatory Framework

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Profiles/Listing
    • 8.3.1. New York Plastic Surgical Group
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Westlake Dermatology & Cosmetic Surgery
      • 8.3.2.1. Overview
      • 8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Nazarian Plastic Surgery
      • 8.3.3.1. Overview
      • 8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Ruby Surgery & Aesthetics
      • 8.3.4.1. Overview
      • 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Cadogan Clinics
      • 8.3.5.1. Overview
      • 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. UK Aesthetic
      • 8.3.6.1. Overview
      • 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. UK Healthcare Aesthetics Center
      • 8.3.7.1. Overview
      • 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Marroquin & Sandoval Plastic Surgery
      • 8.3.8.1. Overview
      • 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Advanced Cosmetic Surgery.
      • 8.3.9.1. Overview
      • 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Orange County Facial Plastic Surgery.
      • 8.3.10.1. Overview
      • 8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives